Abstract
dc:descriptionL-asparaginase catalyzes the conversion of L-Asn to L-Asp and ammonia. The L-asparaginases from Erwinia chrysanthemi and E. coli are currently in clinical use as effective drugs for the treatment of haemapoietic diseases such as ALL (Acute Lymphoblastic Leukaemia). Over the years many homologous L-asparaginases have been cloned and characterized in order to find enzymes with less toxic effects, since it has been shown that the enzyme's effectiveness, its pharmacokinetic properties and the various side effects depend on its origin and its purification protocol. The aim of the present work is the development of a production procedure of L-asparaginase in E. coli cells and the creation of modified forms of the enzyme with desired properties. Genomic DNA from Erwinia chrysanthemi and Erwinia carotovora was isolated and used as template in PCR reactions for the amplification of the ORFs of the corresponding L-asparaginases. The resulting PCR amplicons were TOPO ligated into the T7 expression vector pCR®T7/CT-TOPO®. The resulting expression constructs were used to transform competent BL21(DE3) pLysS E. coli cells. The Er. carotovora L-asparaginase (EcaL-Asnase) and the Er. chrysanthemi enzyme (ErL-Asnase) were fully characterized. The main restrictions to the use of L-asparaginase as a therapeutic agent include its premature inactivation and rapid clearance, thus necessitating frequent injections to maintain therapeutic levels. For designing a protease-resistant L-asparaginase from Er. carotovora (EcaL-ASNase) chemical modification with succinimide esters of polyethylene glycol (PEG) and site-directed mutagenesis were employed. The final modified form was found to be protease resistant. With a view to create in vitro variants with desired properties, EcaL-ASNase and ErL-ASNase were subjected to directed evolution using the Staggered extension process (StEP). One-hundred transformants of the generated library were screened for low L-glutaminase activity and high thermal stability at 55°C. Two enzyme variants (L90I, G281S) with low L-glutaminase activity and one (D133V) with high thermostability were identified and selected for further study. For the variants L90I and G281S it was shown that they don't recognize L-glutamine as substrate, and the D133V was found to be highly thermostable. To further investigate the role of the residue at position 133 on enzyme thermostability, saturation mutagenesis at position 133 was carried out. Five enzyme variants were selected and studied. The results indicated that the amino acid residue at position 133 contributes significant to the enzyme's structural stability.
Degree
thesis:*- Grantor dc:publisher
- Agricultural University of Athens
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kotzia, Georgia
- Κοτζιά, Γεωργία
Subjects
dc:subject × 20- L-ασπαραγινάση
- Λευχαιμία
- Ενζυμική μηχανική
- Ανθεκτικότητα στην πρωτεόλυση
- Τροποποίηση με PEG
- Κατευθυνόμενη εξέλιξη
- Θερμοσταθερότητα
- Μεταλλαξογένεση κορεσμού
- L-asparaginase
- Leukaemia
- Enzyme engineering
- Proteolytic resistance
- PEGylation
- Directed evolution
- Thermal stability
- Saturation mutagenesis
- Γεωπονικές Επιστήμες και Κτηνιατρική
- Γεωπονική Βιοτεχνολογία
- Agricultural and Veterinary Sciences
- Agricultural Biotechnology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/21637